Home > API & Intermediate > Drug Metabolism > Apremilast Manufacturers > Apremilast

Apremilast

CAS NO.： 608141-41-9

FOB Price： NEGOTIABLE Get Latest Price

Specification： ≥99.5%

Documentation： Get COA after inquiry

Lead Time： 14-30 days

Max Capacity： -

Packing： 25KG/Fibre Drum

Product Detail

Properties

Apremilast

Product Introduction:

Apremilast is an oral phosphodiesterase 4 inhibitor is used in the treatment of psoriatic arthritis.

Synonymous	Otezla
CAS	608141-41-9
Molecular Formula	C₂₂H₂₄N₂O₇S
Molecular Weight	671.577
Appearance	White to grayish white solid
Storage	Low temperature storage at 2-8 ℃
Category	Treatment of psoriatic arthritis (PSA)

Properties

Apremilast is an oral phosphodiesterase 4 inhibitor is used in the treatment of psoriatic arthritis.

CAS No.

608141-41-9

Formula

C22H24N2O7S

Molecular Mass

460.5

Exact Mass

460.13000

PSA

127.46000

Logp

3.52590

IUPAC

N-[2-[(1S)-1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-1,3-dioxoisoindol-4-yl]acetamide

Category

Density

1.381

Boiling Point

741.3±60.0 °C(Predicted)

Appearance

White to grayish white solid

HS Code

UN No.

DG-Class

Send your message to this supplier

To：

Jiangsu Simcere Pharmaceutical Co., Ltd.

Not exactly what you want? One request, multiple quotations Get Quotations Now >>

Supplier's main products

Palonosetron Hydrochloride

Edoxaban(Tosylate Monohydrate)

Jiangsu Simcere Pharmaceutical Co., Ltd.

29YRS

Business Type：

Manufacturing

Country/Region：

Jiangsu, China

Contacts：

Manager Zhu

Position Title：

Manager of foreign trade department

Tel：

0086-25-8556 6666

Email：

simcere@chemmail.net

Visit Factory

Get Free Samples

Less than 1KG required

b

Send Email

Apremilast

Product Introduction: